crispr
Web general
PTAB sides with Broad Institute over University of California on patent priority for use of CRISPR in eukaryotic cells
After a U.S. Court of Appeals asked the Patent Trial and Appeal Board to reconsider its 2022 decision on inventorship of CRISPR-Cas9 uses in eukaryotic cells, the board reaffirmed its original ruling.
Campus & community